The aim of the study is to evaluate the cosmetic features of the product WO 3308 by means of a questionnaire in an interview situation after two weeks of product treatment, giving special consideration to the cosmetic performance, efficacy and skin compatibility and with special focus on the reduction of pruritus. Additionally the tolerance will be evaluated by a dermatologist.

Inclusion Criteria:

• age: ≥ 18 years
• sex: approx. 25% to 50% male and 50% to 75% female
• with acute pruritus (lasts less than 6 weeks) or chronic pruritus (lasts longer than 6 weeks): max. 50% with acute pruritus and at least 50% with chronic pruritus

Exclusion Criteria:

• any deviation from the above-mentioned criteria
• known incompatibilities to cosmetics and ingredients of cosmetic test products (please see INCI)
• topical medication in the test area within 1 month prior to study start
• systemic medication with antibiotics within 2 weeks prior to starting of the study
• change in the medication with anti-inflammatory agents within 2 weeks prior to starting the study
• systemic medication with immunomodulators (immunsuppressive drugs in the course of a transplantation) and/or chemotherapeutic agents within 4 weeks prior to starting the study
• neurodermatitis (atopic dermatitis)
• pregnancy and period of breastfeeding